DAPT
Dyspnea of Ticagrelor: the challenge and the wise decisions
Ticagrelor is one of the most potent anti-platelets, especially for acute coronary syndrome patients managed with PCI and stenting. However, Ticagrelor induced dyspnea is one of the most annoying adverse effects that may disrupt patients compliance to this vital medication. Some patients may seek re-admission shortly after PCI complaining from this dyspnea, and it may […]